Gastrointestinal bleeding (GIB) is common in patients with continuous-flow left ventricular assist devices (CF-LVADs) possibly because of changes in blood flow. We aimed to test the hypothesis that a low pulsatility index (PI) is associated with an increased hazard of overt GIB in patients with CF-LVADs. We conducted a retrospective cohort study of patients who had a HeartMate II (HMII) CF-LVAD implanted at our center. The study end-point was the first overt GIB causing or occurring during a hospitalization between 6 days and 6 months after HMII implantation. HMII PI was recorded at 48 hours and at 1, 3, and 6 month intervals after implantation. We analyzed the associations of PI and clinical variables with the hazard of overt GIB. Ninety-five patients met eligibility criteria. PI ranged from 2.5 to 5.9 (low PI < 4.15 and high PI ≥ 4.15 on the basis of receiver operating characteristic curve analysis). Seventeen (18%) patients experienced overt GIB. In a multivariable model, only lower baseline hemoglobin was a significant predictor of an increased hazard of overt GIB. After adjusting for the baseline hemoglobin, low PI was independently associated with an increased hazard of overt GIB in our cohort of HMII recipients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MAT.0000000000000766 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Analysis of Anticoagulation Versus Combination Anticoagulation and Antiplatelet Therapy in Atrial Fibrillation Patients Presenting With Gastrointestinal Bleeding.
J Cardiovasc Pharmacol
December 2024
Department of Cardiovascular Medicine, Faculty of Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Patients with atrial fibrillation (AF) taking antithrombotic (AT) therapy are at an increased risk of gastrointestinal bleeding (GIB). The comparative effect of a combination of anticoagulant (AC) and antiplatelet (AP) versus AC monotherapy on clinical outcomes in patients with AF presenting with GIB is not well characterized. This study compares outcomes in AF patients with GIB on AC alone with those on combination AP and AC therapy, as part of a larger prospective study from 2013 to 2023.
View Article and Find Full Text PDFDetection of Gastrointestinal Bleeding With Large Language Models to Aid Quality Improvement and Appropriate Reimbursement.
Gastroenterology
January 2025
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut; Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut; Clinical and Translational Research Accelerator, Department of Medicine, Yale School of Medicine, New Haven, Connecticut. Electronic address:
Article Synopsis
- The study focuses on using a generative AI pipeline to enhance the identification of overt gastrointestinal bleeding (GIB) in electronic health records, ultimately improving patient management and reimbursement accuracy.
- The pipeline was developed using nursing notes from over 11,000 patients and demonstrated high accuracy in detecting various forms of bleeding, such as melena and hematochezia.
- Results showed that the machine learning model for recurrent bleeding had exceptional diagnostic performance, and the reimbursement algorithm significantly increased average patient reimbursements by up to $3,247, resulting in millions of dollars in total reimbursement.
Comparison of gastrointestinal bleeding in patients with and without liver cirrhosis.
Scand J Gastroenterol
September 2024
Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Objectives: Upper gastrointestinal bleeding (GIB) in patients has been well-characterized in liver cirrhosis but studies on lower GIB are limited. The clinical characteristics, management and outcomes in patients with and without liver cirrhosis was compared to determine the overall features of GIB in patients with liver cirrhosis compared with non-cirrhotics.
Methods: A retrospective study on cirrhotics hospitalized for GIB 2010-2021, matched with control group of non-cirrhotics (1:4) for upper vs.
Clinical characteristics and outcomes of overt gastrointestinal bleeding in children undergoing haploidentical hematopoietic stem cell transplantation: a single-center retrospective analysis.
BMC Pediatr
July 2024
Laboratory of Pediatric Hematology, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, 100 Hong Kong Road, Wuhan, 430015, China.
Article Synopsis
- Overt gastrointestinal bleeding (GIB) is a serious condition commonly seen in children undergoing haploidentical hematopoietic stem cell transplantation (haplo-HSCT), with a noted incidence of 25.2%.
- The study reviewed 123 pediatric patients over a median follow-up of 26.3 months and found that GIB negatively impacted overall survival and increased non-relapse mortality.
- Key risk factors for developing overt GIB included severe gut acute graft versus-host disease, thrombotic microangiopathy, and cytomegalovirus viremia.
Validation of an Electronic Health Record-Based Machine Learning Model Compared With Clinical Risk Scores for Gastrointestinal Bleeding.
Gastroenterology
November 2024
Section of Digestive Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut; West Haven Veterans Affairs Medical Center, West Haven, Connecticut.
Article Synopsis
- Guidelines suggest using risk scores to identify very-low-risk patients with gastrointestinal bleeding (GIB) for possible discharge from emergency departments.
- A new machine learning model was developed and tested against existing scores (Glasgow-Blatchford and Oakland) using data from nearly 3,500 patients across different hospitals.
- Results showed the machine learning model performed better in predicting very-low-risk patients, successfully identifying a higher percentage compared to the existing risk scores.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!